MedMira, Inc. (CVE:MIR) | WebDisclosure

Basculer en Français

10656	Companies
226865	Keywords
155336	Articles
120139	Press releases

Home
Companies
MedMira, Inc.

PRESS RELEASE

published on 02/01/2024 at 13:35, 2 years 4 months ago

Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening

MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
PRESS RELEASE

published on 12/30/2023 at 05:00, 2 years 6 months ago

MedMira Reports First Quarter Results FY2024
MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
PRESS RELEASE

published on 12/14/2023 at 04:30, 2 years 6 months ago

U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
PRESS RELEASE

published on 11/29/2023 at 05:00, 2 years 7 months ago

MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
PRESS RELEASE

published on 09/28/2023 at 04:00, 2 years 9 months ago

Update on MedMira’s Regulatory Path in Canada and the USA
PRESS RELEASE

published on 08/31/2023 at 04:00, 2 years 9 months ago

Progress Update on Securities
PRESS RELEASE

published on 06/30/2023 at 04:00, 3 years ago

MedMira Reports Third Quarter Results FY2023
PRESS RELEASE

published on 04/04/2023 at 03:00, 3 years 2 months ago

MedMira Reports Second Quarter Results FY2023
PRESS RELEASE

published on 03/14/2023 at 21:31, 3 years 3 months ago

Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
PRESS RELEASE

published on 02/20/2023 at 23:00, 3 years 4 months ago

MedMira Enters into Partnership with Maternova for USA and Latin America

Accesswire

Published on 06/30/2026 at 05:30, 1 hour 31 minutes ago

Nano One Renews At-The-Market Equity Program
Published on 06/30/2026 at 02:00, 5 hours 1 minute ago

MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 00:05, 6 hours 56 minutes ago

American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 7 hours 15 minutes ago

1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 9 hours ago

AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders

View all ACCESSWIRE

EQS Group

Published on 06/30/2026 at 06:25, 35 minutes ago

Risen Energy signs multiple European partners at Intersolar Europe to accelerate European expansion
Published on 06/29/2026 at 22:47, 8 hours 13 minutes ago

Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 8 hours 56 minutes ago

ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 8 hours 56 minutes ago

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 10 hours 31 minutes ago

Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items

Les Echos

Published on 06/29/2026 at 18:30, 12 hours 31 minutes ago

Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 12 hours 31 minutes ago

Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 13 hours 16 minutes ago

Successful issue of a € 1.5 billion bond
Published on 06/29/2026 at 17:45, 13 hours 16 minutes ago

Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 13 hours 16 minutes ago

Déclaration hebdomadaire de rachat d'actions

View all LES ECHOS COMFI WIRE